» Articles » PMID: 17665245

Increased Risk of Lymph Node Metastasis in Multifocal Hereditary and Sporadic Medullary Thyroid Cancer

Overview
Journal World J Surg
Publisher Wiley
Specialty General Surgery
Date 2007 Aug 1
PMID 17665245
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: In sporadic and hereditary medullary thyroid cancer, tumor multifocality may constitute an independent risk factor of lymph node metastasis on top of primary tumor size when the diameter of the largest primary tumor is the same.

Methods: Included in this institutional cohort study were 232 consecutive patients operated on at our institution for hitherto untreated medullary thyroid cancer. Associations of clinicopathologic variables with lymph node metastasis were investigated simultaneously using multivariate Cox regression analysis.

Results: On univariate analysis, multifocal cancers developed lymph node metastases significantly more often (p < or = 0.005) than unifocal cancers, in both the sporadic (90% vs. 41%) and the hereditary setting (48% vs. 14%). On multivariate Cox regression analysis on lymph node metastasis as a function of primary tumor diameter, only multifocal (vs. unifocal) tumor growth was significantly associated with lymph node metastasis (odds ratio [OR] = 2.5; p = 0.01). When multifocal growth was removed as an independent variable from the Cox model, heredity became the only significant predictor (OR = 3.1; p < 0.0001).

Conclusion: The excess risk of lymph node metastasis of 34%-49% in multifocal medullary thyroid cancer seems to be caused by concurrent smaller thyroid cancers. A diagnosis of more than one medullary thyroid cancer signifies a higher risk of lymph node metastasis, warranting systematic lymph node dissection.

Citing Articles

Can ACR TI-RADS predict the malignant risk of medullary thyroid cancer?.

Zhang Y, Ye B, Wang H, Liu B, Liu Y, Wei Q J Clin Transl Endocrinol. 2025; 39():100380.

PMID: 39811784 PMC: 11732179. DOI: 10.1016/j.jcte.2024.100380.


Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma.

Guo F, Fu G, Li F, Hua Y, Wang Z, Zheng X World J Surg Oncol. 2024; 22(1):121.

PMID: 38711029 PMC: 11071271. DOI: 10.1186/s12957-024-03397-3.


Changes of biochemical factors and the effect on recurrence of medullary thyroid carcinoma after surgery.

Guo F, Li L, Gu P, Zhang G, Ruan X, Zhao J Heliyon. 2024; 10(8):e29857.

PMID: 38681571 PMC: 11046226. DOI: 10.1016/j.heliyon.2024.e29857.


The Evolving Treatment Landscape of Medullary Thyroid Cancer.

Lagana M, Cremaschi V, Alberti A, Vodopivec Kuri D, Cosentini D, Berruti A Curr Treat Options Oncol. 2023; 24(12):1815-1832.

PMID: 37979019 PMC: 10781862. DOI: 10.1007/s11864-023-01145-5.


Risk factors of cervical lymph node metastasis in multifocal papillary thyroid cancer.

Zhang T, He L, Wang Z, Dong W, Sun W, Zhang P Front Oncol. 2022; 12:1003336.

PMID: 36568187 PMC: 9773975. DOI: 10.3389/fonc.2022.1003336.


References
1.
Machens A, Niccoli-Sire P, Hoegel J, Frank-Raue K, van Vroonhoven T, Roeher H . Early malignant progression of hereditary medullary thyroid cancer. N Engl J Med. 2003; 349(16):1517-25. DOI: 10.1056/NEJMoa012915. View

2.
Roher H, Simon D, Goretzki P . [Guidelines in oncologic surgery--malignant thyroid tumors]. Langenbecks Arch Chir Suppl Kongressbd. 1997; 114:142-5. View

3.
Raffel A, Cupisti K, Krausch M, Wolf A, Schulte K, Roher H . Incidentally found medullary thyroid cancer: treatment rationale for small tumors. World J Surg. 2004; 28(4):397-401. DOI: 10.1007/s00268-003-7121-6. View

4.
Machens A, Gimm O, Ukkat J, Hinze R, Schneyer U, Dralle H . Improved prediction of calcitonin normalization in medullary thyroid carcinoma patients by quantitative lymph node analysis. Cancer. 2000; 88(8):1909-15. View

5.
Kaserer K, Scheuba C, Neuhold N, Weinhausel A, Haas O, Vierhapper H . Sporadic versus familial medullary thyroid microcarcinoma: a histopathologic study of 50 consecutive patients. Am J Surg Pathol. 2001; 25(10):1245-51. DOI: 10.1097/00000478-200110000-00004. View